Literature DB >> 16097564

Verification films: a study of the daily and weekly reproducibility of breast patient set-up in the START trial.

K Venables1, E A Miles, P J Hoskin, E G A Aird.   

Abstract

AIMS: Verification of patient position in radiotherapy by the use of portal images is a current practice in most radiotherapy departments. All patients within the Standardisation of Breast Radiotherapy Trial (START) were required to have on-treatment verification images. Measurements of maximum lung and breast depth from these were used to provide details for the case-report forms. This study was undertaken to validate these measurements, assess the reproducibility of patients' set-up within the START trial and to compare reproducibility on a day-to-day basis with reproducibility over a longer period. Analysis also included a subjective assessment of image quality.
MATERIALS AND METHODS: Fifty-three patients from 29 departments were studied. Some centres used electronic portal imaging and others used film. Where film verification was the method of choice, information was collected about the type of film and cassette used.
RESULTS: The correlation coefficients for inter- and intra-observer variability of breast and lung depth were 0.99. Comparing maximum breast depth on weekly and daily images, the median per cent standard deviation of breast depth was 4% and 3%, respectively. The mean standard deviation of breast depth for all patients, which gives an indication of the individual patient variability, was 5.5 +/- 2.2 mm for weekly and 3.9 +/- 1.5 mm for daily measurements. For lung depth, mean standard deviation was 6.8 +/- 2.5 mm for weekly and 6.8 +/- 2.8 mm for daily measurements. Images taken using Kodak X-omat V film were inferior to those taken with films in corresponding cassettes.
CONCLUSION: Differences between lung depth measured in simulator and on the treatment unit were evident for many patients. There was little difference in the standard deviations of breast and lung depth for daily and weekly verification films on the treatment machine.

Entities:  

Mesh:

Year:  2005        PMID: 16097564     DOI: 10.1016/j.clon.2005.03.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  5 in total

1.  Correction of systematic set-up error in breast and head and neck irradiation through a no-action level (NAL) protocol.

Authors:  Eva M Lozano; Luis A Pérez; Javier Torres; Carmen Carrascosa; Miguel Sanz; Fermín Mendicote; Antonio Gil
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

2.  Impact of the frequency of online verifications on the patient set-up accuracy and set-up margins.

Authors:  Volker Rudat; Mohamed Hammoud; Yogin Pillay; Abdul Aziz Alaradi; Adel Mohamed; Saleh Altuwaijri
Journal:  Radiat Oncol       Date:  2011-08-24       Impact factor: 3.481

Review 3.  Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Authors:  Mareike K Thompson; Philip Poortmans; Anthony J Chalmers; Corinne Faivre-Finn; Emma Hall; Robert A Huddart; Yolande Lievens; David Sebag-Montefiore; Charlotte E Coles
Journal:  Br J Cancer       Date:  2018-07-31       Impact factor: 7.640

4.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet       Date:  2008-03-19       Impact factor: 79.321

5.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet Oncol       Date:  2008-03-19       Impact factor: 41.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.